会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Enhanced gene expression in algae
    • 藻类中增强的基因表达
    • US08476019B2
    • 2013-07-02
    • US13504741
    • 2010-11-01
    • George OylerJulian Rosenberg
    • George OylerJulian Rosenberg
    • C12Q1/68
    • C12N15/79C07K14/415C12N15/8216
    • The invention provides a system of enhancing the expression of transgenes in algae. Transgenes are engineered to have a binding site for certain proteins in proximity to their promoter, for example a LexA binding site. The algae is also engineered to express a nucleosome alteration protein fused to a protein with affinity to the DNA binding site acting in coordination. An example is a LexA-p300 fusion protein, where the p300 is derived from Chlamydomonas. The LexA binding domain guides the p300 to the binding site and the p300 loosens the nucleosome structure by acetylating histones within proximity of the transgene, thus remodeling the local chromatin structure to allow for high-level expression.
    • 本发明提供增强藻类中转基因表达的系统。 转基因被设计为具有接近其启动子的某些蛋白质的结合位点,例如LexA结合位点。 藻类也被设计成表达与蛋白质融合的核小体变异蛋白质,其与DNA结合位点具有亲和性,起协调作用。 一个例子是LexA-p300融合蛋白,其中p300衍生自衣藻。 LexA结合结构域将p300引导到结合位点,p300通过在转基因附近乙酰化组蛋白来松开核小体结构,从而重建局部染色质结构以允许高水平表达。
    • 2. 发明申请
    • ENHANCED GENE EXPRESSION IN ALGAE
    • 在ALGAE中增强基因表达
    • US20120208201A1
    • 2012-08-16
    • US13504741
    • 2010-11-01
    • George OylerJulian Rosenberg
    • George OylerJulian Rosenberg
    • C12Q1/68C12N1/12
    • C12N15/79C07K14/415C12N15/8216
    • The invention provides a system of enhancing the expression of transgenes in algae. Transgenes are engineered to have a binding site for certain proteins in proximity to their promoter, for example a LexA binding site. The algae is also engineered to express a nucleosome alteration protein fused to a protein with affinity to the DNA binding site acting in coordination. An example is a LexA-p300 fusion protein, where the p300 is derived from Chlamydomonas. The LexA binding domain guides the p300 to the binding site and the p300 loosens the nucleosome structure by acetylating histones within proximity of the transgene, thus remodeling the local chromatin structure to allow for high-level expression.
    • 本发明提供增强藻类中转基因表达的系统。 转基因被设计为具有接近其启动子的某些蛋白质的结合位点,例如LexA结合位点。 藻类也被设计成表达与蛋白质融合的核小体变异蛋白质,其与DNA结合位点具有亲和性,起协调作用。 一个例子是LexA-p300融合蛋白,其中p300衍生自衣藻。 LexA结合结构域将p300引导到结合位点,p300通过在转基因附近乙酰化组蛋白来松开核小体结构,从而重建局部染色质结构以允许高水平表达。
    • 3. 发明授权
    • Methods for identifying inhibitors of botulinum neurotoxins
    • 鉴定肉毒杆菌神经毒素抑制剂的方法
    • US07632917B2
    • 2009-12-15
    • US11095055
    • 2005-03-31
    • Randall L. KincaidGeorge OylerYen Che TsaiPaul S. Fishman
    • Randall L. KincaidGeorge OylerYen Che TsaiPaul S. Fishman
    • C07K14/00A61K39/08
    • C07K14/705C12Q1/37G01N33/5014G01N2500/04
    • A system and method for identifying a botulinum neurotoxin inhibitor employing a botulinum neurotoxin substrate complex having a peptide substrate, preferably SNAP-25, a reporter domain on one side of said peptide substrate and an immobilization domain on the opposite side of said peptide substrate. The botulinum neurotoxin inhibitor is identified by its ability to decrease the relative amount of cleaved complex, detected through measuring a decrease in complex bound to a solid support. The method of the present invention also utilizes novel cells that express a botulinum neurotoxin substrate complex. The methods of the present invention are adapted for cell based screening to monitor the catalytic activity of a BoNT in living cells and to identify molecules that inhibit the catalytic activity of a BoNT in living cells. Also provided are novel stable cell lines that express the botulinum toxin substrate complex and viral vectors capable of efficiently expressing an active light chain of the BoNT within mammalian cells.
    • 一种使用具有肽底物的肉毒杆菌神经毒素底物复合物鉴定肉毒杆菌神经毒素抑制剂的系统和方法,优选SNAP-25,所述肽底物一侧的报道结构域和所述肽底物相反侧的固定结构域。 肉毒杆菌神经毒素抑制剂通过其降低切割复合物的相对量的能力来鉴定,通过测量与固体支持物结合的复合物的降低来检测。 本发明的方法还利用表达肉毒神经毒素底物复合物的新细胞。 本发明的方法适用于基于细胞的筛选以监测活细胞中BoNT的催化活性并鉴定抑制活细胞中BoNT的催化活性的分子。 还提供了表达肉毒杆菌毒素底物复合物的新型稳定细胞系和能够在哺乳动物细胞内有效表达BoNT活性轻链的病毒载体。
    • 6. 发明授权
    • Methods for identifying inhibitors of botulinum neurotoxins
    • 鉴定肉毒杆菌神经毒素抑制剂的方法
    • US08093044B2
    • 2012-01-10
    • US12630336
    • 2009-12-03
    • Randall KincaidGeorge OylerYien Che TsaiPaul S. Fishman
    • Randall KincaidGeorge OylerYien Che TsaiPaul S. Fishman
    • C07K14/00A61K39/08C12N5/10
    • C07K14/705C12Q1/37G01N33/5014G01N2500/04
    • A system and method for identifying a botulinum neurotoxin inhibitor employing a botulinum neurotoxin substrate complex having a peptide substrate, preferably SNAP-25, a reporter domain on one side of said peptide substrate and an immobilization domain on the opposite side of said peptide substrate. The botulinum neurotoxin inhibitor is identified by its ability to decrease the relative amount of cleaved complex, detected through measuring a decrease in complex bound to a solid support. The method of the present invention also utilizes novel cells that express a botulinum neurotoxin substrate complex. The methods of the present invention are adapted for cell based screening to monitor the catalytic activity of a BoNT in living cells and to identify molecules that inhibit the catalytic activity of a BoNT in living cells. Also provided are novel stable cell lines that express the botulinum toxin substrate complex and viral vectors capable of efficiently expressing an active light chain of the BoNT within mammalian cells.
    • 一种使用具有肽底物的肉毒杆菌神经毒素底物复合物鉴定肉毒杆菌神经毒素抑制剂的系统和方法,优选SNAP-25,所述肽底物一侧的报道结构域和所述肽底物相反侧的固定结构域。 肉毒杆菌神经毒素抑制剂通过其降低切割复合物的相对量的能力来鉴定,通过测量与固体支持物结合的复合物的降低来检测。 本发明的方法还利用表达肉毒神经毒素底物复合物的新细胞。 本发明的方法适用于基于细胞的筛选以监测活细胞中BoNT的催化活性并鉴定抑制活细胞中BoNT的催化活性的分子。 还提供了表达肉毒杆菌毒素底物复合物的新型稳定细胞系和能够在哺乳动物细胞内有效表达BoNT活性轻链的病毒载体。
    • 8. 发明申请
    • METHODS FOR IDENTIFYING INHIBITORS OF BOTULINUM NEUROTOXINS
    • 用于鉴定嗜碱性粒细胞毒素抑制剂的方法
    • US20100204054A1
    • 2010-08-12
    • US12630336
    • 2009-12-03
    • Randall L. KincaidGeorge OylerYien Che TsaiPaul S. Fishman
    • Randall L. KincaidGeorge OylerYien Che TsaiPaul S. Fishman
    • C40B30/04C12N1/20G01N33/53
    • C07K14/705C12Q1/37G01N33/5014G01N2500/04
    • A system and method for identifying a botulinum neurotoxin inhibitor employing a botulinum neurotoxin substrate complex having a peptide substrate, preferably SNAP-25, a reporter domain on one side of said peptide substrate and an immobilization domain on the opposite side of said peptide substrate. The botulinum neurotoxin inhibitor is identified by its ability to decrease the relative amount of cleaved complex, detected through measuring a decrease in complex bound to a solid support. The method of the present invention also utilizes novel cells that express a botulinum neurotoxin substrate complex. The methods of the present invention are adapted for cell based screening to monitor the catalytic activity of a BoNT in living cells and to identify molecules that inhibit the catalytic activity of a BoNT in living cells. Also provided are novel stable cell lines that express the botulinum toxin substrate complex and viral vectors capable of efficiently expressing an active light chain of the BoNT within mammalian cells.
    • 一种使用具有肽底物的肉毒杆菌神经毒素底物复合物鉴定肉毒杆菌神经毒素抑制剂的系统和方法,优选SNAP-25,所述肽底物一侧的报道结构域和所述肽底物相反侧的固定结构域。 肉毒杆菌神经毒素抑制剂通过其降低切割复合物的相对量的能力来鉴定,通过测量与固体支持物结合的复合物的降低来检测。 本发明的方法还利用表达肉毒神经毒素底物复合物的新细胞。 本发明的方法适用于基于细胞的筛选以监测活细胞中BoNT的催化活性并鉴定抑制活细胞中BoNT的催化活性的分子。 还提供了表达肉毒杆菌毒素底物复合物的新型稳定细胞系和能够在哺乳动物细胞内有效表达BoNT活性轻链的病毒载体。